Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
The immunotherapy led to an improvement in survival for people with gastric or gastroesophageal junction cancers with a high PD-L1 level.
HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.
A low dose of platinum-based chemotherapy worked as well as higher doses for elderly and frail people with esophageal and stomach cancer.
Median overall survival was 5.7 months for patients receiving Lonsurf and 3.6 months for those receiving placebo.
Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.
Keytruda improved survival in people with favorable tumor biomarkers.
Sarah Rafat is a registered dietitian at the University of Texas MD Anderson Cancer Center in Houston.
November is Stomach Cancer Awareness Month.
Liver fat may be a driver of increased cancer risk associated with obesity.
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer.
Women with the chronic condition are 6 percent more likely than men to develop cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.